News Link 101

 

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 101

Making history: from a public health emergency to a polio-free world 

Accelerating progress on women’s and children’s health

Success factors for reducing maternal and child mortality

UN must pick up the pace on sustainable finance 

The World Health Organization: no game of thrones

World Bank Group Commitments Rise Sharply in FY14 Amid Organizational Change 

Pharmaceutical Industry: an asset of the European Economy

PHARMACEUTICAL INDUSTRY: A STRATEGIC SECTOR FOR THE EUROPEAN ECONOMY  

European Commission: Action Plan on the enforcement of Intellectual Property Rights  

GlaxoSmithKline’s China scandal: A cautionary tale? 

International investment agreements and public health: neutralizing a threat through treaty drafting 

A BRICS Wall Facing West 

EU-BRAZIL PARTNERSHIP ON DEVELOPMENT: A LUKEWARM AFFAIR – ANALYSIS

African Development Bank on the move 

Reforms to Food Aid in the Farm Bill will Help Spur Local Markets 

ONE applauds AU Malabo Declaration’s re-commitment to agriculture transformation  

Are Money Transfer Monopolies Keeping African Families in Poverty? 

Learning from a “Living Laboratory”: 5 Lessons for the Green Climate Fund  

AFSA Submission for Urgent  Intervention in Respect to Draft ARIPO Plant Variety Protection Protocol (PVP) and Subsequent  Regulations 

Conducting clinical trials for sleeping sickness in remote areas of the Democratic Republic of the Congo – Overcoming operational challenges and reaping health system benefits

Fexinidazole study for sleeping sickness extended to new patient groups 

La violenza sulle donne. Il caso indiano 

Copertura sanitaria universale e equità. Il momento delle scelte 

AIDS. Lo scandalo del vaccino italiano 

 

 

 

News link 100

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 100

Open letter from Civil Society groups to Minister Rob Davies and the Newly Appointed Cabinet on the Urgent Need to Finalise and Adopt South Africa’s National IP Policy

Eliminating inequality and the threat of climate change key to new UN development goals

UN Advisor Denounces Junk Food As ‘Culprit’ In Rising NCDs, Calls For Change

Chile, China and Morocco join others in moving closer to eradicating hunger

Small Farmers’ Rights Sidelined In Uganda’s Plant Breeding Regulation

NGOs blame Berlin for feeding big business land grabs

How can food security interventions be more sustainable?

How to feed a hungry planet

UN urges G77+China to unite on combating poverty, climate change

Not Just ‘Women’s Issues’: Including Women in the Growth Agenda

5 Practical Actions to Help Free Imprisoned Sudanese Mother

A Call to Prioritize Gender in Development

Donors Should Put Evidence Before Politics and Diplomacy

Sustainable development: Show, don’t tell

Toilets for all: a big challenge for India’s government

Partnership commerciale tra Usa e Ue: L’Italia avrà un ruolo fondamentale

Partire è un poco morire. Malattie infettive nelle popolazioni immigrate nell’Unione Europea

Sud Africa. I progressi e le sfide

Ospedali for profit in Africa. Il caso Lesotho

Come s’insegna Medicina nell’Università Fluminense, Rio de Janeiro-Brasil

 

 

 

 

 

 

 

News Link 99

 

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 99

Commission rejects call to respect right to life in development aid 

Council for Trade-Related Aspects of Intellectual Property Rights – Non-violation complaints under the TRIPS Agreement – Communication from the United States

TRIPS Council Debates Non-Violations, Innovation, Green Tech Transfer 

Development Progress LAUNCH: Pathways to Progress in Health 

UN group chairs unveil zero draft for sustainable development goals 

The Brussels G7 Summit Declaration 

Oxfam on G7 summit: Stronger steer needed on energy security, climate change and the global economy 

Shared Responsibilities for Health: A Coherent Global Framework for Health Financing  

Growing concerns over medicines agency’s proposed rules for transparency  

Africa and the New European Parliament: How Much Change Can We Expect? 

Civil society leaders to meet in advance of US-Africa summit   

A healthier South Africa through continued ANC dominance?   

Vaccines Europe: Call for Action 

Access To Vaccines, Patents Growing Concerns, Panellists Say 

Why Must We Pay Attention to Women’s Economic Empowerment? 

Kellogg & General Mills: Feed people, fight climate change! 

Change the way the food companies that make your favorite brands do business  

Sustainable Energy Supply Models Discussed At UNESCO Conference 

Q&A: Developing World Leads in Advancement of Climate Change Laws

Pollution Deaths Soar but Aid Is Cut  

African Intellectual Property Organization (OAPI) Becomes Second Intergovernmental Organization to Join UPOV     

How to Beat Malaria, Once and for All 

Fight the Fakes Campaign: Partners  

A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010   

Mind the gaps – the epidemiology of poor-quality anti-malarials in the malarious world – analysis of the WorldWide Antimalarial Resistance Network database  

Quality of Antimalarial Drugs and Antibiotics in Papua New Guinea: A Survey of the Health Facility Supply Chain 

A Tiered Analytical Approach for Investigating Poor Quality Emergency Contraceptives

Measuring Wealth to Track Sustainability

New CONCORD president: Show development’s ‘positive impact’

No excuses in Chagas diagnosis  

Fear and ignorance aid spread of Ebola

How ‘rogue’ is China’s aid?  

 

 

 

 

News Link 98

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 98

The human embryo is “One of Us”: help us to protect and respect its dignity and integrity   

Petition To Save Meriam Ibrahim Yehya 

Making fair choices on the path to universal health coverage

What is the Open Policy Network? 

Open A.I.R. Project Publications 

The Open African Innovation Research and Training (Open A.I.R.) Project 

Commodities for better health in Africa – time to invest locally

Innovation & IP – Collaborative Dynamics in Africa 

Knowledge & Innovation in Africa – Scenarios for the Future 

BRICS and global health 

BRICS cooperation in strategic health projects

BRICS seek value for money as health-care costs rise 

The BRICS countries: a new force in global health? 

Relative health performance in BRICS over the past 20 years: the winners and losers 

Socioeconomic inequalities and mortality trends in BRICS, 1990–2010

BRICS: opportunities to improve road safety 

Progress towards universal health coverage in BRICS: translating economic growth into better health 

Impact of BRICS’ investment in vaccine development on the global vaccine market  

The economic and social benefits of childhood vaccinations in BRICS 

BRICS’ role in global health and the promotion of universal health coverage: the debate continues 

Tracking the flow of health aid from BRICS countries 

Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda 

BRICS in the response to neglected tropical diseases 

BRICS’ contributions to the global health agenda 

Inquinamento atmosferico nelle città del mondo: il database dell’Oms 

Le emissioni di gas a effetto serra accelerano 

Fears over policy based on ‘planetary boundaries’ model 

UNDP cuts HQ staff, creates new lower-level jobs

Italy won’t let corruption stop dev’t aid to Mindanao

Obesity rising  

 

 

 

 

Financing Research for Health: Why the Multilateral Process Paused, and What Action Governments Should Take rather than Wait

Many low and middle-income countries (LMICs) are still struggling to finance indigenous R&D, and several are failing to meet continental declarations of intent such as the African Union target of 1% of GDP on R&D. In the next two years, LMICs may make significant strides in pushing their own R&D models, but it is clear that a radical re-think of how to fund, and how to incentivise R&D is needed if they are to get drug development for diseases of poverty resourced. A bold new strategy requires perspectives including the voice of NGOs and civil society, if progress in R&D is to result in greater access and health equity. This is why LMICs should take the lead and not rely on external aid nor wait for international treaties to arrange what they can start and fund at home

Financing Research for Health: Why the Multilateral Process Paused, and What Action Governments Should Take rather than Wait

by 

 Priya Shetty Global Health Consultant, Brighton, UK  

Danny Edwards Council on Health Research for Development (COHRED*), Geneva, Switzerland

Carel IJsselmuiden COHRED, University of KwaZulu-Natal, Pietermaritzburg, South Africa

 

There are some problems in global health that seem so intractable as to defy solution: one of these is the flawed model of research and development (R&D). Developing new drugs and vaccines is so expensive that a market-based system simply cannot support the millions of dollars needed in investment when these medicines are being developed for people who cannot afford costly drugs and are without health insurance.

For a while in 2012, it seemed as if the world would see a much-awaited R&D treaty that would revolutionise funding of global health research. This time, it also looked like the pharmaceutical industry was on board, a major coup considering that the business goals of industry are often not in alignment with ensuring that the world’€™s poorest have access to cheap medicines. But hopes were dashed when the idea was once again placed on the backburner until 2016, a decision reached in May 2013 at the 66th World Health Assembly in response to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG).

Many in global health saw this as enormously disappointing news, and with good reason. The restrictions of intellectual property laws still limit the  production of generic medicines, and gains in access to generic drugs are under constant threat of reversal, particularly for the most costly drugs. Despite the launch of ventures such as the Drugs for Neglected Diseases Initiative (DNDi), neglected diseases such as trachoma and Buruli ulcer still garner pitiful amounts of attention, and even less funding. Last year, with the exception of the USA, high-income country governments cut their funding for neglected diseases by an average of 20%.

Under pressure to take some action after the multilateral process stalled, governments agreed to create a Global R&D Observatory to improve monitoring and evaluation of health research financing, and to identify “€œdemonstration projects“to test mechanisms for boosting global R&D financing. These projects should help us understand better what sort of incentives -€“ such as an R&D prize fund -€“ could entice researchers to target particular R&D goals.

However, the eight demonstration projects that were chosen a year later, last December, left many, especially civil society and NGOs such as MSF underwhelmed. The criteria for selecting the projects were revealed so close to the meeting as to leave no time for critique or input, and while the projects seem entirely robust scientifically, they did not yet prioritize testing price-delinkage mechanisms -€“ yet the fact that the high cost of R&D is linked to the price of the final product is central to the reason that the current system is broken. Demonstration projects that fall closely in line with the existing system will only prove a circular argument – that if a project is designed to work within the current system, it will succeed. Yet this is far from what is needed. These considerations are without prejudice to a just approved resolution by the 67th WHA that allows WHO to establish a pooled fund for sustainable R&D for developing countries, based upon delinking drug prices from the cost of the R&D.

Worryingly, it seems there is a real possibility that, in 2016, we will be no closer to understanding how to devise a global R&D treaty, and that the demonstration projects will have revealed very little about radical and innovative ways to fund global R&D, especially for health problems faced by those with fewest resources. Other commentators  have variously described the process as a ‘€˜non-event’€™, that is ‘€˜based on flawed logic’, and will ‘€˜waste time and money’€™.

The multilateral process to develop an R&D treaty failed for many reasons. A key explanation is that two of the biggest global R&D funders, the USA and the European Union, were opposed to the financial reform aspects of the treaty, which would demand fixed contributions of GDP towards R&D from member states and would ensure that 20% of this funding is channeled through a pooled funding mechanism. Other major criticisms centered on the absence of any serious engagement with civil society or NGOs, and more critically, on the heavy-handed involvement of the pharmaceutical industry and its attempt to co-opt the R&D agenda, although it is perhaps not surprising that the pharmaceutical companies would not wholeheartedly support a treaty that proposed radical reform in how it does business.

All of this suggests that it is time for the global health community to be bolder in how it deals with this issue. WHO member states are understandably conservative when it comes to international agreements, and agreeing on a treaty that is acceptable to all is not an easy task. But the world has proven that when it wants to, such as in enforcing stricter tobacco control, it can be both co-operative and innovative.

Despite the somewhat dispiriting lack of action at the international level, there are significant actions that low and middle-income countries (LMICs) themselves can take – and indeed are already taking – to push for a better R&D system.

For instance, several new financing mechanisms, with control firmly in the hands of LMICs, are being floated. Recently, a BRICS Bank was created which would fund infrastructure and sustainable development in LMICs. Now, BRICS countries have agreed to fund the bank with $100 billion, which could weaken the dominance of funding agencies such as the World Bank in global aid. BRICS partnerships  and South-South partnerships are starting to flourish too, with India and Israel setting up a joint US$40 million fund for technology ventures, with each country investing US$20 million over 5 years.

Many LMICs are still struggling to finance indigenous R&D, however, and several are failing to meet continental declarations of intent such as the African Union target of 1% of GDP on R&D. Relying on external aid, however, means that countries risk loss of autonomy in setting their research agenda. At COHRED’€™s 2013 Colloquium in Geneva, participants suggested that LMICs set up dedicated national research funds (NRFs) as a way of ensuring that research funding is disbursed in accordance with explicitly linked local priorities. South Africa set up such a fund in 1998. Indonesia, currently in the midst of radical science and technology reform, is planning to set up a NRF, as are many African countries such as Burkina Faso, Burundi, Ghana and Kenya.

The possible benefits of such an approach are numerous. It can fund systematically, ensuring that research funds do not dry up halfway through a project: a perennial issue in low-income countries. It can raise research quality by instituting a competitive process based on merit, meaning that funding does not go to only the well connected. It can fund institutional and management capacity, areas less popular with international funders. It can be aligned with national research agendas, ensuring funded research accords to country need as is the case in most high-income countries. Even though allocating a percentage of a low national budget will not immediately replace the need for global health research funding, it directly supports LMIC autonomy in setting their own priorities and setting the tone and direction of their own research and innovation systems.

For the least-developed countries, other events also indicate that the time is right to build R&D infrastructure. On 11-12 June last year, the World Trade Organization (WTO) Council on the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), agreed that least-developed countries do not have to comply with the global intellectual property rights framework for a further eight years beyond 2013. This provides them greater freedom to build up their technological base (as India did before WTO accession in 2005) and the policy space to experiment with alternative models for incentivising R&D.

In the next two years, LMICs may make significant strides in pushing their own R&D models, but it is clear that a radical re-think of how we fund, and how we incentivise R&D is needed if we are to get drug development for diseases of poverty resourced. It is evident that processes run entirely by member states are too often mired in politics as to be actionable. A bold new strategy requires new perspectives, especially from those outside of the system, including the voice of NGOs and civil society – if progress in R&D is to result in greater access and health equity. This is why LMICs should take the lead and not wait for international treaties to arrange what they can start and fund at home.

——————————————————————————-

*COHRED, the Council on Health Research for Development, is a global, non-profit organisation whose singular goal is to maximize the potential of research and innovation to deliver sustainable solutions to the health and development problems of people living in low and middle-income countries

News Link 97

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 97

EU diplomats agree to 7% biofuels cap 

The US Farm Bill: What implications for Africa? 

The global cotton market has changed: What does it mean for African producers?  

How does the US Farm Bill affect food security in Sub-Saharan Africa? 

World No Tobacco Day 2014: Raise taxes on tobacco, a proven weapon of mass destruction!   

Huge divide over Uganda’s HIV prevention bill 

South African Trade Minister Davies: Election Result May Mean Fast Action On IP Policy  

New EU framework for protection of trade secrets

How the new Global Fund-WHO partnership will work 

WHO Executive Board Wraps Up Post-WHA Work  

Developing Entrepreneurial Spirit in Nigeria 

“We Are Not Job-Seekers, We Are Job-Creators”– Turning Unemployment into Entrepreneurship 

Lagarde Urges Africa to Act on Poverty 

Africa Developing Unified Climate Strategy 

Advancing Global Food Security in the Face of a Changing Climate

Modi’s daunting development  task 

5 Predictions for India’s Development Cooperation Under New Government  

What you may have missed: Narendra Modi’s message to China 

The Latest Health Wonk Review 

For Telehealth Patient Safety Insists Upon An Evolution In Policy

White-washing e società scientifiche 

WHO: update on the Geneva buildings  renovation strategy

World Bank says half of proposed $400 million savings found

World Bank leaders planning staff cuts 

Spare the rod – the biology of poverty and violence

Rapporto Osservasalute 2013. Stato di salute e qualità dell’assistenza nelle regioni italiane 

 

 

 

 

 

Radio Vaticana: Intervista a GESPAM

Medicine Salvavita per Tutti, non solo per chi se le può permettere

Oltre la metà  dei 5 miliardi di abitanti nei paesi del sud del mondo conta su meno di due dollari al giorno per la sussistenza, mentre il fenomeno della contraffazione e cattiva qualità  dei prodotti farmaceutici lievita e le medicine salvavita sono vincolate a regimi brevettuali esacerbati da accordi di libero scambio e da politiche governative sbilanciate a favore di €™interessi di monopolio.

Per cercare di €™informare, sensibilizzare e stimolare un dibattito attorno a questi temi è nato GESPAM, acronimo di ‘Geopolitica, Salute Pubblica, Accesso alle Medicine’€™. GESPAM è un ramo operativo di Equilibri, Agenzia Italiana di Geopolitica e Relazioni Internazionali.

Ne parla ai nostri microfoni, Daniele Dionisio, medico infettivologo, membro del Gruppo di Lavoro del Parlamento Europeo ‘€˜Innovation, Access to Medicines and Poverty-Related Diseases’€™ e fondatore di GESPAM:

http://it.radiovaticana.va/news/2014/05/14/medicine_salvavita_per_tutti_accesso_alla_salute_per_tutti/1100496# 

 

News Link 96

 

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 96

9 important takeaways from #WHA67 

WHO To Develop Global Action Plan Against Antibiotic Resistance 

World Health Assembly Approves Plan To Strengthen Access To Essential Medicines  

WHO Agrees Plan For Sustainable R&D For Developing Countries; TDR May Host Pooled Fund  

World Health Assembly 23 May 2014 Framework of engagement with non-State actors 

WHO Members Note Reform Progress, Ask For Speedy Implementation   

World Health Assembly Adopts Resolution On Hepatitis; Member States Concerned Over High Prices 

WHA: Experts Discuss Methods For Innovation, Access For MICs

World Health Assembly Approves Resolution On Combatting Tuberculosis  

After anti-gay law, new bill threatens fight against HIV in Uganda 

Modern drug discovery and the fight against NTDs: How can the PDP model enhance and accelerate the R&D process? 

Demonstration Financing: Considerations for a Pilot Pooled international fund for r&d 

Paediatric HIV Treatment Initiative (PHTI) to Spur Innovation and Access to Improve the Lives of Children Living with HIV 

DNDi Receives Support from Norwegian Agency for Development Cooperation for its Research & Development on Sleeping Sickness 

How to feed the world when the new generation doesn’t want to go into farming  

“When the sun is shining, our crops are dying”

Climate change and EU security policy: an unmet challenge 

‘Beyond GDP’ is code for anti-prosperity  

Why Jeffrey Sachs matters  

Health Policy Research And Disparities: A Health Affairs Conversation With Lisa Simpson And Darrell Gaskin 

Chile and Costa Rica: Different roads to universal health in Latin America 

8 Facts about China’s Investments in Africa 

 

The Process of Decentralization in Lebanon: South Beirut Municipalities are Improving Primary Healthcare Services and Integrated Local Welfare

The Lebanese Health care system is very fragmented due to the lack of a public health policy, strategic planning of services and their organizational structures. Now, through a new process of decentralization, South Beirut Municipalities are improving primary healthcare services and integrated local welfare

The Process of Decentralization in Lebanon: South Beirut Municipalities are Improving Primary Healthcare Services and Integrated Local Welfare

fotochighine_n

by Cinzia Chighine*

 Tuscany Region, International Activities

 

The conflict between Israel and Lebanon in July 2006 and the internal repercussions in Lebanon have outlined a new political and economic scenario. Moreover, the internal contradictions and the external interference have negatively influenced the Lebanese economic growth.

According to the Social Action Plan of the Ministry of Social Affairs, the Lebanese Government Budget, historically oriented to multi-year strategies in the Social and Educational field,  has been totally re-planned in order to meet the new Emergency.

Sustained political and security instability have further widened the fiscal deficit and capped Lebanon’€™s GDP growth near 1 percent in 2014, as the International Institute of Finance declared in a revised assessment of the country’€™s economic situation.

The current scenario shows  four main challenges that will weigh on the Lebanese economic performance:  the Presidential election during the year, the formation of a new Government in Lebanon and an escalation of the civil war in Syria, while the frequency of violent incidents in Lebanon has increased.

A Presidential Election was held in Lebanon on 23rd April 2014. Since no candidate reached a two-thirds majority vote, a second round had been scheduled for April 30, a third round for May 15, and a fourth round for May 22. Due to lack of quorum the elections had been aborted.

The Syrians fled to Lebanon  since the outbreak of the civil war are more than one million and they are causing a strong impact on the economy of the Country, for which the United Nations are now asking for urgent international aid. By now the number of refugees, half of whom are children, is equivalent to a quarter of the Lebanese population and according to the United Nations High Commissioner for Refugees, Antònio Guterres, the flow is accelerating.

Today Lebanon ranks 38 out of 135 countries concerning the Poverty Index and it is in 78th place out of 179 as concerning the Human Development Index. Twenty-two percent  of the Lebanese Population is under 15 years and 12% over 60. Life Expectancy is around 73 years. Child Mortality Rate is around 18/1000, while the Maternal Mortality Rate is around 25 per 100,000 live births (2013).

Even in the Health sector there are some critical aspects that represent significant challenges for the public insurance system. The per capita public expenditure in Health services is out of a total of $ 235.8 while the total per capita Health spending is  $ 923 (2013). Public expenditure on total Health expenditure is 5.8% (data from WHO 2013).

In terms of chronic diseases, there is a prevalence of diabetes (12%), hypertension (32%) and obesity (29% over 20 years).

The Sustainable Health system is normally guaranteed by the repayment for each performance initially covered by the public insurance. The costs are aggravated by the repetition of single performances, by some inappropriateness of care pathways and by inappropriate admissions. Considering these anomalies, the overall costs of the Health system -taking into account the overall volume of the performance- are particularly high: the total health expenditure is around 13% of Lebanese GDP with the unfavorable balance between cost/efficiency and cost/benefit.

The poor offer of Basic Health Services and the not always appropriate prevention, such as the lack of continuity of care and inequity of access to them, are important critical points of the system.

The setting of the private Health and Education system does not favor the widespread access to basic rights for a broad segment of the population.

The Lebanese Health Service consists of 90% by individuals and private facilities structures that deliver performances in hospitals, clinics or in local specialized districts in which they operate.

The specialist medical visits, hospitalizations, laboratory examinations, rehabilitation services are reimbursed by 80 % by the public or private insurance companies. However, about 50% of the general population is excluded by the insurance system. Only those who have a job in the private or public sector enjoy the right to the mandatory health insurance.

Lebanese population loses the insurance coverage with the attainment of the retirement age, except for a few and privileged categories of people. The State reimburses only the costs of first aid hospitalization to them, according to no more adequate rates, because they have been agreed in the past.

The Lebanese Health care system is very fragmented due to the lack of a public health policy, strategic planning of services and their organizational structures. Accordingly, an excessive commercialization of health services increases the gap between rich and poor people.

According to Ministry of Public Health (MoPH) database, the insurance coverage in Lebanon is the following:

Social Security – “€œDaman”€ 26.1%

Cooperative of Government employees 5.5%

Army 9.1%

Security facilities 2.2%

Private insurance 8.8%

Ministry of Public Health 48.3%

About 50% of the Lebanese  population (unemployed people and almost all of the elderly population) is excluded from the public or private insurance system. According to the National Health Program of Lebanese MoPH, the State reimburses only the costs of hospitalization and the first aid service to these citizens. A partial role in filling gaps is covered by various religious congregations and some local NGOs to whom a part of the poor population is referring to.

According to MoPH Database, in addition to the public Health structures managed by the MoPH (nr. 15 units), by MoPH/NGOs and Municipality (nr.14 units), by Ministry of Social Affairs (nr. 3 unit), by NGOs (nr. 53 units) and by the Municipality itself (nr. 1 unit), there are about 800 dispensaries, managed by Lebanese NGOs, to whom only 15% of the population, in large part not covered by insurance, is addressed.

The network of the dispensaries – created as a quick  response to post-war emergencies – is suffering from the lack of minimum quality standards and professional skills in the offered services, and it would require a rethinking in a perspective of public reorganization of basic services.

In 2007 the rethinking of the concept and the prerogatives of dispensaries started in several municipalities in the southern suburbs of Beirut, among the areas most affected by the conflict. The South Beirut dispensaries have been transformed into Primary Care Centers (PHCC) and one of these centers is being accredited by the MoPH.

The Southern Suburbs of Beirut -called Dahiye – include eight municipalities, some of which have been particularly hardly hit by Israeli bombing in 2006. During the conflict many people from southern Lebanon have settled in these suburbs often occupying the skeletons of buildings destroyed by the civil war and never rebuilt.

The Social and Health care services offered to the local population in these areas are extremely limited and not incorporated into the regular activities of the municipalities.

The Lebanese administrative decentralization process -despite an ongoing reform deeply desired by the Lebanese Chairman, in order to incorporate the  recommendations of the Ta’if Agreement (1989) – is  essentially quite new.

The local government is represented by the Municipalities, as the Districts (Mohafazat in Arabic) don’€™t’ have political power in terms of delivery of services to citizens and are not beneficiaries of the financial resources by the central government.

The Lebanese Municipalities -as revealed by a study conducted by the “€œCenter for Administrative Innovation in the Euro-Mediterranean region” €(CAIMED)- don’t have developed relationships with the citizens they are dealing with. The Municipalities provide basic services i.e. Tax collection, without actually establishing links with the people.

Recently, some Municipalities have joined together in  “€œUnion of Municipalities”€.

The “€œOffice of the Minister of State for Administrative Reform”€ (OMSAR) highlights – among the main difficulties it has to deal with in his role as a facilitator for the effective application of the administrative law reform – the lack of support by local governments as they are not ready to change. Actually, the forms of cooperation between different Lebanese actors are limited by the legacy of the civil war.

Lebanon has been the scene of many conflicts, mainly due to its complex social, religious and political composition.

The repercussions of these events fall on the Lebanese people who are still  living situations characterized by poverty, unemployment, lack of opportunities, conflicts and widespread violence at the local level.

The national political instability has not activated the processes of decentralization. The municipalities are representative bodies with small margin of direct intervention on the needs of the population.

The Issue of Health is a strategic factor to strengthen, through the implementation of operational tools, the governance of the territories, exchanges and more dialectical confrontation among the Government Institutions. At the same time , Health Policies are influenced by environmental, economic, social and political issues, that directly affect the community. The Health integrated approach is therefore a “€œroadway”€ for local authorities to strengthen  their role thus gaining its political-administrative function.

In the framework of the UNDP ART Gold program, the Region of Tuscany supports the network among Social Offices of the Municipalities, offices for local development (LEDA) and the Centers for Primary Care (PHCCs), particularly in the suburbs of South Beirut, in order to reinforce, in accordance with the MoPH, the local health systems in areas affected by the now highly migratory flow of Syrian refugees.

The initiative aims to support the general goal of the administrative decentralization process. The PHCCs will reinforce the role of local authorities as public providers in the Municipalities of Al Mreyjeh, Al Chiah and Furn Al Chebbak,  Haret Hreik, Ghobeiry, Tyre, North Akkar Region, in accordance with the recommendations of the Ministry of Health in order to adopt a new approach to Primary Care through the Social Offices.

The experience has allowed to break the fragmentary in the Lebanese Health Sector, improving the population’s access to basic services through the implementation of a modern integrated system of Primary Care.

The network of PHCCs is able to generate operational synergies with the Education system through permanent programs of Education and Health promotion, Health education , prevention and care.

Particularly, the Region of Zgharta, deeply affected by the emergence of the Syrian refugee population is involving PHCCs in a new integrated approach to the Local Welfare.

————————————————————————-

 *Cinzia Chighine, born in Viareggio (Italy) in 1974, has been professionally active as aid-worker in Africa and Middle East area for a decade. She works now in Florence as a staff member of Tuscany Region’€™s International Activities Department

News Link 95

 

The news links are part of the research project GESPAM (Geopolitica, Salute Pubblica e Accesso alle Medicine/Geopolitics, Public Health and Access to Medicines), which aims to focus on the best options for the use of trade and government rules related to public health by resource-limited countries

 

News Link 95

IP, R&D Among Issues In Packed Agenda Of 2014 World Health Assembly  

World Health Assembly 2014 — 3 things to look out for in Geneva 

People’s Health Movement Commentary on the Agenda of the 67th World Health Assembly  

WHO: Increasing access to HIV treatment  in middle-income countries. Key data on prices, regulatory status, tariffs and the intellectual property situation

New Initiative To Address Lack Of Paediatric-Specific HIV Treatments

EU and UNICEF launch ‘Voices of Children in Emergencies’ joint campaign  

EU more than doubles vaccine aid as Gavi launches appeal   

No Excuse Left but Biotech: Will the United States start a smallpox threat creation program? 

Statement of the Joint PAS/PASS Workshop on Sustainable Humanity, Sustainable Nature: Our Responsibility 

EU holds public consultations on TTIP investment chapter 

STOP TTIP Ribaltare l’Europa dei mercati, costruire l’Europa dei diritti 

EPO Internal Strife Spills Over Into European Parliament, Human Rights Court  

Budget 2014: The end of an aid era? 

The Potential Power of Social Crowdfunding   

Il caso del vaccino anti-Aids: Interrogazione al ministro Lorenzin 

Human Rights Organizations Condemn Ugandan Law, Bill Criminalizing Homosexuality, HIV Transmission  

The Power of Procurement: Public Purchasing in the Service of Realizing the Right to Food     

Diseguaglianze, povertà alimentare e salute  

International Seed Treaty Brainstorming For Sustainability   

Special Report – Students To Universities: “We Have A Drug Problem”    

Where Are Chinese Investments in Africa Headed? 

How Climate Change Will Destroy Your Country’s Credit Rating